Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins

Publisher: Karger

E-ISSN: 1421-9751|138|2|122-132

ISSN: 0008-6312

Source: Cardiology, Vol.138, Iss.2, 2017-06, pp. : 122-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content